NCT02976558
The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation No drug interventions treatment Not Available terminated NCT05502887
The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms No drug interventions Not Available Not Available recruiting NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT00410696
Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy No drug interventions treatment 2 completed NCT02544230
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia No drug interventions Not Available Not Available completed NCT00440765
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands No drug interventions Not Available Not Available completed NCT02634294
Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT treatment 2 / 3 completed NCT00440479
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies. No drug interventions Not Available Not Available completed NCT03844360
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease No drug interventions treatment 4 unknown_status NCT00582894
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases No drug interventions treatment Not Available completed NCT01594723
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms No drug interventions treatment 2 active_not_recruiting NCT00001432
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies No drug interventions Not Available Not Available completed NCT02494258
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders treatment 2 active_not_recruiting NCT00001873
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers No drug interventions treatment 2 completed NCT00001872
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease No drug interventions Not Available Not Available completed NCT00001623
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia No drug interventions treatment Not Available completed NCT01855698
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism No drug interventions Not Available Not Available completed NCT00005785
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer No drug interventions treatment 1 completed NCT02745743
Phase I Trial of BAY1251152 for Advanced Blood Cancers No drug interventions treatment 1 completed NCT02635984
Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens No drug interventions supportive_care 3 completed NCT04448184
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) No drug interventions other 3 recruiting NCT04760184
Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden No drug interventions Not Available Not Available completed NCT01802879
Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator No drug interventions treatment 2 completed NCT01362179
National Marrow Donor Program Long-Term Donor Follow-Up No drug interventions Not Available Not Available completed NCT06422533
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients treatment Not Available recruiting NCT00473577
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients No drug interventions treatment 1 completed NCT02329847
A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies treatment 1 / 2 completed NCT02504047
Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units No drug interventions treatment Not Available completed NCT05902845
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL No drug interventions treatment 0 recruiting NCT01915498
Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation treatment 1 / 2 completed NCT04323605
Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant No drug interventions other Not Available unknown_status NCT01021683
The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants Not Available Not Available completed NCT02061761
A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies treatment 1 / 2 completed NCT00389428
Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer. No drug interventions treatment 1 completed NCT02033928
Comprehensive Frailty Assessment No drug interventions Not Available Not Available completed NCT03301493
Genomic Testing and Resulting Medical Decisions No drug interventions Not Available Not Available recruiting NCT02477878
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant treatment 1 active_not_recruiting NCT00698685
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation treatment 2 terminated NCT03320915
Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT treatment 2 unknown_status NCT05549232
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital No drug interventions Not Available Not Available recruiting NCT05882175
Prospective Validation of the OHI Index No drug interventions Not Available Not Available recruiting NCT01332006
Intra-bone Cord Blood Transplantation No drug interventions treatment 2 unknown_status NCT01244906
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant No drug interventions treatment 2 completed NCT06433349
A Multi-center Investigation of Family Health. No drug interventions Not Available Not Available recruiting NCT00421213
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers No drug interventions treatment 2 completed NCT00028418
Clofarabine in Chronic Lymphocytic Leukemia No drug interventions treatment 1 completed NCT01869218
Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy No drug interventions Not Available Not Available completed NCT01374841
Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors treatment 2 recruiting NCT03288441
Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT02367196
A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers treatment 1 completed NCT00997386
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States treatment 2 completed NCT00001748
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies No drug interventions treatment 1 completed NCT00750126
Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 unknown_status NCT04871165
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals No drug interventions Not Available Not Available unknown_status NCT05054231
Immunological Profile for Patients Treated With CAR-T Cells No drug interventions basic_science Not Available not_yet_recruiting NCT00038376
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies No drug interventions treatment 2 completed NCT02650791
Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study other 3 completed NCT04303091
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients No drug interventions other Not Available completed NCT05819762
Evaluation of ClearLLab LS Screening Panel No drug interventions Not Available Not Available recruiting NCT02958462
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study No drug interventions screening Not Available recruiting NCT00957580
Trial of Pimasertib in Hematological Malignancies treatment 2 terminated NCT03743480
Early Palliative Care and Hematological Cancer Patients No drug interventions supportive_care Not Available unknown_status NCT04310592
Natural Killer Cell (CYNK-001) Infusions in Adults With AML No drug interventions treatment 1 recruiting NCT03680092
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation No drug interventions treatment 2 active_not_recruiting NCT03575767
Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT No drug interventions Not Available Not Available completed NCT04264767
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA No drug interventions Not Available Not Available completed NCT03349372
Impact of Pulmonary Follow-up After Stem Cell Graft No drug interventions Not Available Not Available completed NCT03648372
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System No drug interventions treatment 1 / 2 terminated NCT01790568
Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant No drug interventions prevention 2 completed NCT05061095
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey No drug interventions Not Available Not Available completed NCT00900614
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer No drug interventions treatment 1 completed NCT03983850
Optimizing PTCy Dose and Timing No drug interventions treatment 1 / 2 recruiting NCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT05907603
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) No drug interventions treatment 0 recruiting NCT03023202
UWCCC Molecular Tumor Board Registry No drug interventions Not Available Not Available recruiting NCT04691284
Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation No drug interventions basic_science Not Available recruiting NCT00987987
Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion No drug interventions treatment 1 / 2 completed NCT04275154
Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy No drug interventions Not Available Not Available withdrawn NCT05602051
Mindfulness-based Virtual Reality Intervention No drug interventions supportive_care Not Available recruiting NCT03136445
TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia No drug interventions supportive_care 3 completed NCT00071045
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members No drug interventions Not Available Not Available recruiting NCT00526045
Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients No drug interventions treatment 1 / 2 completed NCT02944045
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients No drug interventions treatment 3 unknown_status NCT00051311
Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers No drug interventions treatment 2 completed NCT02623309
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients No drug interventions treatment 3 completed NCT05256537
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil No drug interventions treatment 2 active_not_recruiting NCT00044759
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma No drug interventions treatment 3 completed NCT04959175
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT03403075
Therapeutic Education in Physical Activity (ETAF) No drug interventions treatment Not Available completed NCT00623870
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms. No drug interventions treatment 1 completed NCT00914849
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies No drug interventions treatment 2 completed NCT05716113
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL No drug interventions treatment 0 recruiting NCT06339541
The ACC Preclinical Research Platform for Precision Oncology No drug interventions Not Available Not Available recruiting NCT01275534
Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT03505086
Bleeding In Thrombocytopenia Explained No drug interventions Not Available Not Available recruiting NCT00595686
Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies No drug interventions treatment 1 completed NCT03722186
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies No drug interventions treatment 1 suspended NCT00067730
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation No drug interventions treatment 4 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT03094026
Cognitive Training Intervention and Attitudes Towards Genetics No drug interventions supportive_care Not Available recruiting NCT05672420
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT03087227
Shared Health Information System for Febrile Neutropenia No drug interventions health_services_research Not Available completed NCT03083327
Prophylactic Early PN in HPT/BMT No drug interventions prevention Not Available unknown_status NCT03483194
Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH) No drug interventions other 2 / 3 completed NCT05895994
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies No drug interventions treatment 0 recruiting NCT01488591
Biomarker Research for Personalized Medicine No drug interventions Not Available Not Available unknown_status NCT02193880
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) No drug interventions treatment Not Available completed NCT02895529
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy No drug interventions treatment 4 terminated NCT00312429
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer No drug interventions treatment 1 / 2 completed NCT03735992
Mind-body Medicine for Patients With Malignant Hematological Diseases No drug interventions treatment Not Available recruiting NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms No drug interventions treatment 1 completed NCT00618969
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors No drug interventions treatment 2 completed NCT03908138
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma No drug interventions treatment 4 unknown_status NCT01553461
Transplants With Unlicensed Preserved Cord Blood No drug interventions treatment 1 / 2 recruiting